LYCOS RETRIEVER 
Echo
built 200 days ago
Echo Healthcare Acquisition Corp. is a blank check company that was formed on June 10, 2005 to serve as a vehicle for the acquisition of one or more domestic or international operating businesses in the healthcare industry. On March 22, 2006, Echo consummated its initial public offering ("IPO") of 6,250,000 Units. On March 27, 2006, the Company consummated the closing of 937,500 additional Units subject to the underwriters' over-allotment option. The 7,187,500 Units sold in the IPO (including the 937,500 Units subject to the underwriters' over-allotment option) were sold at an offering price of $8.00 per Unit, which together with the private placement of the 458,333 warrants to certain stockholders and directors of the Company at an offering price of $1.20 per share, generated total gross proceeds of $58,050,000. Of this amount, $54,947,000 was placed in trust. Echo common stock trades on the OTC Bulletin Board under the symbol EHHA.OB.
Source:
EchoStop is an advanced acoustic echo cancellation software algorithm that allows true full duplex communication over a conferencing system, even when the system is used in large spatial environments that may be vulnerable to long reverberation times. The software algorithm's proprietary processing enables seamless residual echo suppression capabilities providing clear communications, even in highly reverberant, live room environments -- from a conference room to a kitchen. EchoStop ... incorporates noise reduction algorithms to reduce the background noise of both input and output audio, thus preventing the accumulation of interfering noise over multi-point conferencing scenarios.
Source:
Echo tools have an outstanding reputation for their superb quality, great practicality, unrivalled reliability and outlasting durability. They are sold in over 80 countries and through more than 16,000 carefully selected and appointed dealers.
Source:
Echo plans to file a Registration Statement on Form S-4 with the Securities and Exchange Commission ("SEC") in connection with the merger, and Echo expects to mail a Proxy Statement/Prospectus to stockholders of Echo concerning the proposed merger transaction. Investors and security holders of Echo are urged to read the registration statement and proxy statement/prospectus and the other relevant materials carefully when they become available because they will contain important information about Echo, XLNT, the merger and related matters. Investors and security holders will be able to obtain the documents free of charge at the SEC's web site at www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by Echo by directing a written request to: Corporate Secretary, Echo Healthcare Acquisition Corp., 8000 Towers Crescent Drive, Suite 1300, Vienna, VA 22182. Investors and security holders are urged to read the proxy statement, prospectus and the other relevant materials when they become available before making any voting or investment decision with respect to the merger.
Source:
The Board of Directors of Echo unanimously recommends that stockholders vote "for" each of the proposals related to the proposed merger transaction. Additional information about the proposed merger and each of the other proposals can be found in the definitive proxy statement/prospectus and supplement. A definitive proxy statement/prospectus relating to the special meeting was filed with the Securities and Exchange Commission (the "SEC") on November 13, 2007 and a subsequent supplement to that proxy statement/prospectus was filed with the SEC on November 27, 2007. The supplement and the entire proxy statement/prospectus are ... available at the Company's website at http://www.echohealthcare.com and as filed at http://www.sec.gov.
Source:
Echo has prepared and filed with the SEC a supplement to its proxy statement/prospectus dated November 12, 2007 with additional information regarding the procedures by which stockholders may exercise their conversion rights. Stockholders who wish to convert their shares should carefully read the supplement to the proxy statement/prospectus in addition to the proxy statement/prospectus generally. Any stockholder wishing to exercise his/her conversion rights must do so by 12:00 midnight, Denver Time, on December 11, 2007. The supplement and the entire proxy statement/prospectus will ... be available at the Company's website at http://www.echohealthcare.com and at http://www.sec.gov.
Source:
MORE ABOUT
Echo